New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
04:55 EDTMRGE, MRGE, KND, KND, IMMU, IMMU, COO, COO, CVS, CVS, ARNA, ARNA, GMED, GMED, ISIS, ISIS, Q, Q, STML, STML, BDSI, BDSI, DEPO, DEPOWells Fargo to hold a conference
2014 Healthcare Conference to be held in Boston on June 17-18.
News For MRGE;BDSI;STML;Q;ISIS;GMED;ARNA;CVS;COO;IMMU;KND;DEPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
February 9, 2016
06:53 EDTCVSCVS Health reports Q4 pharmacy same store prescription volumes up 5%
06:53 EDTCVSCVS Health reports Q4 SSS up 3.5%
Subscribe for More Information
06:52 EDTCVSCVS Health reports Q4 adjusted EPS $1.53, consensus $1.53
Reports Q4 revenue $41.15B, consensus $4.18B.
05:40 EDTDEPODepomed initiated with a Buy at UBS
Subscribe for More Information
February 8, 2016
14:28 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
10:22 EDTDEPOOak Ridge reports 5.04% passive stake in Depomed
10:00 EDTBDSI, DEPOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:03 EDTDEPODepomed announces favorable Markman ruling in Nucynta, Nucynta ER litigation
Subscribe for More Information
07:58 EDTCVSCVS Health volatility elevated into Q4 and outlook
Subscribe for More Information
07:44 EDTQQuintiles added to Franchise Pick List at Jefferies
Jefferies analyst David Windley added Quintiles to his firm's Franchise Pick List saying the company has more "large, ingrained relationships" than any other Contract Research Organization despite the underperformance of the shares. The analyst has a Buy rating on the stock with an $82 price target.
06:35 EDTBDSIBioDelivery Sciences initiated with an Overweight at Piper Jaffray
Subscribe for More Information
06:34 EDTDEPODepomed initiated with an Overweight at Piper Jaffray
Subscribe for More Information
February 5, 2016
12:33 EDTIMMUImmunomedics upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
09:32 EDTIMMUImmunomedics granted breakthrough therapy designation for sacituzumab govitecan
Immunomedics announced that its lead investigational antibody-drug conjugate, sacituzumab govitecan, or IMMU-132, has received Breakthrough Therapy Designation from the FDA for the treatment of patients with triple-negative breast cancer who have failed at least 2 prior therapies for metastatic disease.
09:29 EDTIMMUImmunomedics granted Breakthrough Therapy Designation from FDA for IMMU-132
Subscribe for More Information
February 3, 2016
16:05 EDTIMMUImmunomedics sees Phase 3 PANCRIT-1 trial completing enrollment in 2016
Subscribe for More Information
16:03 EDTIMMUImmunomedics reports Q2 EPS (15c), two estimates (14c)
Subscribe for More Information
09:32 EDTCVSCVS Health initiated with an Overweight at Atlantic Equities
Target $114.
February 1, 2016
13:20 EDTCVSCVS Health to make overdose-reversing drug available without prescription in OH
Subscribe for More Information
10:51 EDTCVSActive calls; INTC CVS TWTR APC BAC
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use